Showing results (191-200 of 242) with videos related to

Sort By:
Pageof 25
Journal of Cancer Research and Clinical Oncology|September 3, 2015
Diagnostic and prognostic value of bladder cancer-related transcript markers in urineJuliane Schmidt, Catharina Propping, Woei-Yun Siow, et al.
International Journal of Cancer|April 25, 2009
Gene signatures of pulmonary metastases of renal cell carcinoma reflect the disease-free interval and the number of metastases per patientDaniela Wuttig, Barbara Baier, Susanne Fuessel, et al.
World Journal of Urology|February 22, 2011
The muscarinic receptor antagonist propiverine exhibits α(1)-adrenoceptor antagonism in human prostate and porcine trigonumMelinda Wuest, Lambertus P Witte, Martina B Michel-Reher, et al.
Neoplasia (New York, N.Y.)|July 2, 2008
Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping arrayMarieta I Toma, Marianne Grosser, Alexander Herr, et al.
European Urology Focus|July 30, 2017
Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks AnalysisMalte W Vetterlein, Thomas Seisen, Matthias May, et al.
International Journal of Cancer|March 18, 2004
D-PCa-2: a novel transcript highly overexpressed in human prostate and prostate cancerBernd Weigle, Andrea Kiessling, Reinhard Ebner, et al.
The Prostate|March 12, 2005
D-TMPP: a novel androgen-regulated gene preferentially expressed in prostate and prostate cancer that is the first characterized member of an eukaryotic gene familyAndrea Kiessling, Bernd Weigle, Susanne Fuessel, et al.
Genes, Chromosomes & Cancer|November 6, 2012
PARK2 and PACRG are commonly downregulated in clear-cell renal cell carcinoma and are associated with aggressive disease and poor clinical outcomeMarieta I Toma, Daniela Wuttig, Sandy Kaiser, et al.
BJU International|November 11, 2014
Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-makingAtiqullah Aziz, Shahrokh F Shariat, Florian Roghmann, et al.
The Prostate|February 17, 2006
Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase I clinical trialSusanne Fuessel, Axel Meye, Marc Schmitz, et al.
Pageof 25